---
schema_version: "secwatch.filing_event.v1"
accession: "0000064803-23-000049"
form_type: "8-K"
ticker: "CVS"
cik: "0000064803"
company_name: "CVS HEALTH Corp"
filed_at: "2023-12-05T23:59:59+00:00"
generated_at: "2026-06-07T18:21:33.357858+00:00"
event_type: "other"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CVS Health initiates FY24 guidance of at least $8.50 adj EPS, raises dividend 10%

## Summary
- Introduces CVS CostVantage and CVS Caremark TrueCost for transparent pharmacy reimbursement, launch in 2025.
- Launches CVS Healthspire brand for Health Services segment including Caremark, Oak Street, Signify, MinuteClinic.
- Reiterates FY23 guidance; initiates FY24 projections: revenue >=$366B, adj EPS >=$8.50.
- Board approves quarterly dividend increase to $0.665/share (+10%), payable Feb 1, 2024.
- Aetna achieves 87% of Medicare Advantage members in 4-star+ plans for 2025, up from 21%.

## SEC filing metadata
- accession: 0000064803-23-000049
- form_type: 8-K
- ticker: CVS
- cik: 0000064803
- company_name: CVS HEALTH Corp
- filed_at: 2023-12-05T23:59:59+00:00
- event_type: other
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/64803/000006480323000049/0000064803-23-000049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/64803/000006480323000049/cvs-20231205.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000064803-23-000049
- JSON: https://secwatch.observer/filing/0000064803-23-000049.json
- Plain text: https://secwatch.observer/filing/0000064803-23-000049.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.